Showing 1 - 20 results of 25 for search 'Victor Jiménez‐Yuste', query time: 0.07s Refine Results
  1. 1
    Evaluation of the the dynamic group “what’s up?” Perceived efficacy for self-care and mutual learning in a health care team

    Evaluation of the the dynamic group “what’s up?” Perceived efficacy for self-care and mutual learning in a health care team by Javier Barbero, Patricia Fernández-Herreruela, Helena García-Llana, Olga Mayoral-Pulido, Víctor Jiménez-Yuste

    Published 2014-01-01
    Get full text
    Article
  2. 2
    Considerations for shared decision management in previously untreated patients with hemophilia A or B

    Considerations for shared decision management in previously untreated patients with hemophilia A or B by Jan Astermark, Jan Blatný, Christoph Königs, Cédric Hermans, Victor Jiménez-Yuste, Daniel P. Hart

    Published 2023-04-01
    Get full text
    Article
  3. 3
    Hemofilia: naturaleza de las visitas a urgencias pediátricas

    Hemofilia: naturaleza de las visitas a urgencias pediátricas by Paula García Sánchez, Julia Martín Sánchez, María Isabel Rivas Pollmar, María Teresa Álvarez Román, Víctor Jiménez Yuste

    Published 2019-12-01
    Get full text
    Article
  4. 4
    Haemophilia: Reasons for visits to the paediatric emergency department

    Haemophilia: Reasons for visits to the paediatric emergency department by Paula García Sánchez, Julia Martín Sánchez, María Isabel Rivas Pollmar, María Teresa Álvarez Román, Víctor Jiménez Yuste

    Published 2019-12-01
    Get full text
    Article
  5. 5
    A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma

    A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma by Jose Manuel Martin de Bustamante, Ana Mendoza, Samuel López-Muñoz, Eugenia García-Fernández, Pilar Gómez-Prieto, Victor Jiménez-Yuste

    Published 2023-05-01
    Get full text
    Article
  6. 6
    Radiosynovectomy for the Treatment of Chronic Hemophilic Synovitis: An Old Technique, but Still Very Effective

    Radiosynovectomy for the Treatment of Chronic Hemophilic Synovitis: An Old Technique, but Still Very Effective by Emerito Carlos Rodriguez-Merchan, Hortensia De la Corte-Rodriguez, Maria Teresa Alvarez-Roman, Primitivo Gomez-Cardero, Victor Jimenez-Yuste

    Published 2022-12-01
    Get full text
    Article
  7. 7
    Surgical Experience from the STASEY Study of Emicizumab Prophylaxis in People with Hemophilia A with Factor VIII Inhibitors

    Surgical Experience from the STASEY Study of Emicizumab Prophylaxis in People with Hemophilia A with Factor VIII Inhibitors by Giancarlo Castaman, Flora Peyvandi, Johanna A. Kremer Hovinga, Roger E.G. Schutgens, Susan Robson, Katya Moreno, Víctor Jiménez-Yuste

    Published 2024-01-01
    Get full text
    Article
  8. 8
    The Limitations and Unmet Needs of the Five Cornerstones to Guarantee Lifelong Optimization of Prophylaxis in Hemophilia Patients

    The Limitations and Unmet Needs of the Five Cornerstones to Guarantee Lifelong Optimization of Prophylaxis in Hemophilia Patients by Ramiro Núñez, María Teresa Álvarez-Román, Santiago Bonanad, José Ramón González-Porras, Hortensia De La Corte-Rodriguez, Rubén Berrueco, Víctor Jiménez-Yuste

    Published 2022-10-01
    Get full text
    Article
  9. 9
    Complications and Implant Survival of Total Knee Arthroplasty in People with Hemophilia

    Complications and Implant Survival of Total Knee Arthroplasty in People with Hemophilia by Emerito Carlos Rodriguez-Merchan, Hortensia De la Corte-Rodriguez, Teresa Alvarez-Roman, Primitivo Gomez-Cardero, Carlos A. Encinas-Ullan, Victor Jimenez-Yuste

    Published 2022-10-01
    Get full text
    Article
  10. 10
    Acquired Haemophilia A: A 15-Year Single-Centre Experience of Demography, Clinical Features and Outcome

    Acquired Haemophilia A: A 15-Year Single-Centre Experience of Demography, Clinical Features and Outcome by Raisa Guerrero Camacho, María Teresa Álvarez Román, Nora Butta Coll, Damaris Zagrean, Isabel Rivas Pollmar, Mónica Martín Salces, Mercedes Gasior Kabat, Víctor Jiménez-Yuste

    Published 2022-05-01
    Get full text
    Article
  11. 11
    Fixed doses of N8‐GP prophylaxis maintain moderate‐to‐mild factor VIII levels in the majority of patients with severe hemophilia A

    Fixed doses of N8‐GP prophylaxis maintain moderate‐to‐mild factor VIII levels in the majority of patients with severe hemophilia A by Pratima Chowdary, Manuel Carcao, Pål A. Holme, Victor Jiménez‐Yuste, Steven R. Lentz, Judi Møss, Lone H. Poulsen, Chunduo Shen, Alberto Tosetto, Allison Wheeler, Elena Santagostino

    Published 2019-07-01
    Get full text
    Article
  12. 12
    Insights into the Procoagulant Profile of Patients with Systemic Lupus Erythematosus without Antiphospholipid Antibodies

    Insights into the Procoagulant Profile of Patients with Systemic Lupus Erythematosus without Antiphospholipid Antibodies by Elena Monzón Manzano, Ihosvany Fernández-Bello, Raúl Justo Sanz, Ángel Robles Marhuenda, Francisco Javier López-Longo, Paula Acuña, María Teresa Álvarez Román, Víctor Jiménez Yuste, Nora V. Butta

    Published 2020-10-01
    Get full text
    Article
  13. 13
    Management of Urgent Bleeding in Patients with Hemophilia A: Focus on the Use of Emicizumab

    Management of Urgent Bleeding in Patients with Hemophilia A: Focus on the Use of Emicizumab by Víctor Jiménez-Yuste, María T. Álvarez-Román, Rubén Berrueco, Santiago Bonanad, José M. Calvo-Villas, Rebeca González-González, José R. González Porras, Ramiro J. Núñez-Vázquez, Manuel Rodríguez-López

    Published 2024-04-01
    Get full text
    Article
  14. 14
    International consensus recommendations on the management of people with haemophilia B

    International consensus recommendations on the management of people with haemophilia B by Daniel P. Hart, Davide Matino, Jan Astermark, Gerard Dolan, Roseline d’Oiron, Cédric Hermans, Victor Jiménez-Yuste, Adriana Linares, Tadashi Matsushita, Simon McRae, Margareth C. Ozelo, Sean Platton, Darrel Stafford, Robert F. Sidonio, Andreas Tiede

    Published 2022-04-01
    Get full text
    Article
  15. 15
    Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1–3

    Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1–3 by Michael U. Callaghan, Elina Asikanius, Michaela Lehle, Johannes Oldenburg, Johnny Mahlangu, Marianne Uguen, Sammy Chebon, Rebecca Kruse‐Jarres, Víctor Jiménez‐Yuste, Midori Shima, Peter Trask, Christine L. Kempton, Craig M. Kessler, Gallia G. Levy, Flora Peyvandi

    Published 2022-08-01
    Get full text
    Article
  16. 16
    Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance

    Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance by Roger E.G. Schutgens, Victor Jimenez-Yuste, Miguel Escobar, Anna Falanga, Bruna Gigante, Robert Klamroth, Riitta Lassila, Frank W.G. Leebeek, Michael Makris, Tarek Owaidah, Michelle Sholzberg, Andreas Tiede, David J. Werring, H. Bart van der Worp, Jerzy Windyga, Giancarlo Castaman

    Published 2023-06-01
    Get full text
    Article
  17. 17
    The Importance of Platelet Glycoside Residues in the Haemostasis of Patients with Immune Thrombocytopaenia

    The Importance of Platelet Glycoside Residues in the Haemostasis of Patients with Immune Thrombocytopaenia by Andrés Ramírez-López, María Teresa Álvarez Román, Elena Monzón Manzano, Paula Acuña, Elena G. Arias-Salgado, Mónica Martín Salces, María Isabel Rivas Pollmar, Víctor Jiménez Yuste, Raul Justo Sanz, Sara García Barcenilla, Tamara Cebanu, Elena González Zorrilla, Nora V. Butta

    Published 2021-04-01
    Get full text
    Article
  18. 18
    Impact of COVID-19 Pandemic on Patients with Immune Thrombocytopaenia

    Impact of COVID-19 Pandemic on Patients with Immune Thrombocytopaenia by María-Teresa Álvarez Román, Víctor Jiménez Yuste, Sara García Barcenilla, Andrés Ramírez López, Elena Monzón Manzano, Beatriz de la Cruz Benito, Paula Acuña Butta, María Isabel Rivas Pollmar, Roberto Trelles Martínez, Elena González Zorrilla, Mónica Martín Salces, Tamara Cebanu, Nora V. Butta

    Published 2021-03-01
    Get full text
    Article
  19. 19
    Immune Tolerance Induction (ITI) with a pdFVIII/VWF Concentrate (octanate) in 100 Patients in the Observational ITI (ObsITI) Study

    Immune Tolerance Induction (ITI) with a pdFVIII/VWF Concentrate (octanate) in 100 Patients in the Observational ITI (ObsITI) Study by Carmen Escuriola Ettingshausen, Vladimír Vdovin, Nadezhda Zozulya, Pavel Svirin, Tatiana Andreeva, Majda Benedik-Dolničar, Victor Jiménez-Yuste, Lidija Kitanovski, Silva Zupancic-Šalek, Anna Pavlova, Angelika Bátorová, Cesar Montaño Mejía, Gulnara Abdilova, Sigurd Knaub, Martina Jansen, Shannely Lowndes, Larisa Belyanskaya, Olaf Walter, Johannes Oldenburg

    Published 2022-04-01
    Get full text
    Article
  20. 20
    Clinical Efficacy and Safety of Fanhdi, a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study

    Clinical Efficacy and Safety of Fanhdi, a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study by Víctor Jiménez-Yuste MD, PhD, María Teresa Alvarez-Román MD, Ángeles Palomo Bravo MD, Bernardo J. Galmes MD, Maria del Mar Nieto Hernández MD, Olga Benítez Hidalgo MD, Cristina Marzo Alonso MD, Noelia Florencia Pérez González MD, Julia Coll MD, Ramiro Núñez MD, Marina Carrasco MD, Faustino García Candel MD, Jose Ramon Gonzalez-Porras MD, Carmen Hernández García MD, Maria José Varó Castro MD, Roser Mir PhD

    Published 2022-02-01
    Get full text
    Article

Search Tools: